Skip to main content

Biotechnology

University of North Carolina Partners with Dole to Create Research Campus

Published 9/11/2005

The University of North Carolina is partnering with Dole Food Company, North Carolina State University, developer David Murdock, and other institutions to create the 350-acre North Carolina Research Campus in Kannapolis. Upon completion, the campus will comprise over one million square feet of office and laboratory space as well as commercial, retail, and residential facilities. The first 330,000-sf building will include:

Read More

Novartis Plans Cambridge Facility

Published 8/28/2005

The Novartis Institutes for Biomedical Research is planning to construct a new five-story facility adjacent to its existing building in Cambridge, Mass. Sited on land owned by the Massachusetts Institute of Technology, the 60,000-sf facility is expected to begin construction in fall 2005 and reach completion in a year. The project will house Novartis' administrative staff as well as including ground-floor retail space. The architect for the project is Elkus Manfredi of Boston.

Read More

Marshall University Constructs Biotechnology Science Center

Published 8/25/2005

Construction is sixty percent complete on Marshall University 's Robert G. Byrd Biotechnology Center in Huntington, W.V. The $42-million, six-story structure will accommodate two auditoriums, three teaching labs, several conference rooms, and approximately 45 laboratories. Slated for completion in fall 2006, the facility will be open for classes in January 2007. The center is the Marshall University's largest capital improvement project to date.

Read More

Hudson-Alpha Institute for Biotechnology Planned in Huntsville

Published 8/10/2005

The Hudson-Alpha Institute for Biotechnology will construct a $130-million research institute and campus in Huntsville, Ala., by 2007. Sited on 120 acres in the Cummings Research Park, the project will be the second largest biotechnology institute on the second largest biotech campus in the nation upon completion. The north wing will house eight science teams and the south wing will house eight small biotech companies that can expand to sites in the biotech park to accommodate growth.

Read More

Human Genome Sciences Nears Manufacturing Plant Completion

Published 8/7/2005

Human Genome Sciences (HGS) is nearing completion of its $250-million manufacturing facility in Rockville, Md. Sited on ten acres on the Belward Research Campus of Johns Hopkins University near HGS' existing headquarters, the 290,000-sf facility will enable HGS to produce several different biotech drugs on a commercial scale including human proteins, antibodies, and fusion proteins created by the joining of two genes. Construction is expected to reach completion by year-end 2005 with validation of the facility to follow in 2006. 

Read More

Novartis AG Renovates Historic Factory for Biomedical Research

Published 7/15/2005

Swiss pharmaceutical maker Novartis AG has renovated the historic 1927 New England Candy Co. factory in Cambridge to create a 500,000-sf biomedical research facility. The renovated building now houses labs, offices, breakout rooms, a 180-seat auditorium, two conference rooms, and a six-story atrium. Designed to foster interaction and collaboration, the labs and offices are co-located, with breakout rooms and kitchens on the perimeter of each floor. The building features state-of-the-art power, water, air handling, communications, and security systems.

Read More

Worcester Polytechnic Institute Breaks Ground on Bioengineering Center

Published 6/27/2005

Worcester Polytechnic Institute (WPI) broke ground on June 27, 2005 on a life sciences and bioengineering center in Worcester, Mass. Sited on a former industrial brownfield, the 14-story center is the first facility in a planned 11-acre life sciences development called Gateway Parklife sciences park. WPI's 124,600-sf center is slated for completion in early 2007 and will accommodate laboratories, support facilities, and a renovated industrial building housing meeting rooms and offices.

Read More

Nabi Opens Boca Raton Vaccine Plant

Published 6/12/2005

Nabi BioPharmaceuticals dedicated its new 12,000-sf vaccine manufacturing facility in Boca Raton, Fla., in June, 2005. Sited at the company's existing headquarters, the $20-million facility will produce StaphVax, a vaccine for the prevention of hospital-born staph infections.

Read More

Genitope Relocates to Fremont

Published 5/26/2005

Biotechnology firm Genitope is relocating its headquarters and manufacturing operations from Redwood City to 220,0000 sf in Fremont, Calif. Genitope has signed two fifteen and a half year leases for two facilities in the Ardenwood Technology Park at $2.35 per square foot or $517,000 per month. The facilities, which will cost $60 million to build out, will be occupied by Genitope upon completion of construction in 2006.

Read More

Bayer Completes Norwood Lab Facility

Published 4/4/2005

Bayer Healthcare has completed a 100,000-sf office and laboratory facility in Norwood, Mass. Designed by Margulies & Associatesof Boston, the new space consists of 80,000 sf of administrative offices and support areas as well as 20,000 sf of laboratories. Supporting the company's Diagnostics Division, the facility includes visitor and training labs, a test methods lab, an analytical lab, a systems engineering lab, storage for chemicals, and controlled-temperature storage coolers.

Read More

California Institute for Quantitative Biomedical Research Nears Completion

Published 2/17/2005

The $100 million California Institute for Quantitative Biomedical Research is nearing completion at the Mission Bay campus in South San Francisco. The 153,000-sf facility is the first of four buildings that will make up the institute known as QB3 and is connected to U.C. San Francisco's Genentech Hall on all five stories. The Mission Bay facility will house a magnetic resonance imaging machine, a high through-put screening facility, a 250,000-compound chemical library for drug development, and 8,000 CPUs.

Read More

Translational Genomics Completes Phoenix Headquarters

Published 1/30/2005

Translational Genomics (TGen) will officially dedicate its new $46 million headquarters on March 22, 2005. Located in Phoenix, Ariz., the TGen headquarters is sited in a 173,000-sf building, the first in a new downtown campus called the Phoenix Bioscience Center at Cooper Square. Other tenants in the building include the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), occupying the entire 23,000-sf second floor, and the International Genomics Consortium (IGC).

Read More

Clark University Dedicates Center for Bioscience

Published 1/23/2005

Clark University will dedicate the new Cathy '83 and Marc '81 Center for Bioscience on April 28, 2005. Designed by Tsoi/Kobus and Associates of Cambridge, the 50,000-sf facility houses two classrooms; twelve research labs; seven teaching labs; two conference rooms; fourteen faculty offices; a sequencing facility; a dark room; and three lounges.

Read More

CORTEX Develops St. Louis Biotech Building

Published 1/10/2005

Ground has been broken on a new 170,000-sf research laboratory and office facility in St. Louis for the Center of Research, Technology and Entrepreneurial Exchange (CORTEX), a non-profit collaboration of Washington University, St. Louis University, The Barnes-Jewish Hospital Foundation, and the University of Missouri-St. Louis. Designed by HOK, the $36 million project incorporates sustainable design principles and will pursue LEEDTM  certification from the U.S.

Read More